Stockholm Medical Cannabis Conference

Synuclein Synchrony: A Dance of Proteins and Endocannabinoids in Parkinson’s Disease

A breakdown of the Albarran et al. 2023 study from Nature Neuroscience

Scientific Summary:

In the research article titled “Postsynaptic synucleins mediate endocannabinoid signaling” published in Nature Neuroscience, Eddy Albarran and colleagues explore the integral role of synucleins in the regulation of endocannabinoid signaling within postsynaptic neurons. The researchers utilized a combination of electrophysiology and imaging experiments to collect data, which was subsequently analyzed using a suite of software tools.

The study’s central finding is the crucial involvement of synucleins, a family of proteins, in the retrograde release and signaling of endocannabinoids from postsynaptic neurons. Synucleins, particularly alpha-synuclein, are known to be key contributors to Parkinson’s disease (PD). Endocannabinoids, on the other hand, are potent modulators of synaptic transmission across the nervous system, influencing a range of physiological processes from pain sensation to mood regulation and memory.

The research further underscores the role of endocannabinoids in mediating synaptic plasticity within the striatum, a brain region pivotal for motor control and notably affected in Parkinson’s disease. Dysregulation of endocannabinoid signaling within the striatum has been associated with motor deficits in Parkinson’s disease models. Given the central role of alpha-synuclein in PD pathogenesis, its dysregulation could potentially impact endocannabinoid signaling, a critical modulator of synaptic transmission.

Given these findings, it’s plausible that the consumption of phytocannabinoids, which interact with the endocannabinoid system, helps to temporarily restore endocannabinoid signaling in patients with Parkinson’s disease, thereby alleviating some of the symptoms. However, this is a hypothesis that would need to be tested in future studies. It’s also important to note that the effects of phytocannabinoids can vary widely depending on the specific compound and the individual patient’s physiology.


  1. Novelty and Significance: The study uncovers a previously unknown role of synucleins in endocannabinoid signaling, which is a significant contribution to the field of molecular pharmacology. This novel finding could potentially impact our understanding of various neurological disorders where endocannabinoid signaling is implicated.
  2. Robust Methodology: The research employed a combination of electrophysiology and imaging experiments, which are reliable and standard methods in neuroscience research. The use of multiple software tools for data analysis further strengthens the methodology.
  3. Transparency and Reproducibility: The study provides all source data and the code used in the analysis, which promotes transparency and reproducibility of the results. This is a commendable practice in scientific research.


  1. Assumption of Normality: The study assumes a normal data distribution, but this was not formally tested. This could potentially affect the validity of the statistical analyses performed.
  2. Reliance on Software Tools: While the use of software tools for data analysis is a standard practice, any errors or limitations in the software could potentially affect the results. The study does not discuss any potential limitations of the software tools used.
  3. Lack of Information on Potential Confounders: The study does not provide information about any potential confounding factors that could have affected the results. This could potentially limit the interpretation of the findings.

Relevance, Novelty, Significance, and Potential Implications:

The study is highly relevant and novel as it uncovers a new role of synucleins in endocannabinoid signaling. The significance of this finding lies in its potential to impact our understanding of various neurological disorders where endocannabinoid signaling is implicated. The potential implications of this research are vast. It could lead to the development of new therapeutic strategies for these disorders, and it could also guide future research in this field. However, further research is needed to fully understand the implications of these findings.

Stefan Broselid, Ph.D.
Editor-In-Chief, Aurea Care Medical Science Journal


Albarran E, Sun Y, Liu Y, et al. Postsynaptic synucleins mediate endocannabinoid signaling [published online ahead of print, 2023 May 29]. Nat Neurosci. 2023;10.1038/s41593-023-01345-0. doi:10.1038/s41593-023-01345-0